Contributed by William Angelos| 18 March, 2005  07:15 GMT
 'One lesson to be drawn from this case ... is that despite all the advances that have been made in understanding this virus, and all the progress that has been made in developing new drugs, prevention remains the most effective strategy to combat HIV.'
The case of a New York man who developed a unique variant of HIV that is resistant to multiple classes of antiretroviral drugs and is associated with the rapid development of AIDS is the subject of a report in the current issue of The Lancet.
The patient has a history of unprotected sex with multiple partners, and he regularly took the illegal stimulant methamphetamine, researchers note. His infection with HIV resulted in progression to symptomatic AIDS in 4–20 months.
May Be Particularly Agressive Form of HIV
Martin Markowitz of Aaron Diamond AIDS Research Center in New York and colleagues analyzed the genetic makeup of the patient’s virus and assessed its susceptibility to antiretroviral drugs.
Rapid progression to AIDS after infection with HIV-1 has been previously described, as has the transmission of multidrug resistant viruses. However, the unique feature of this report is the combination of these two features -- multidrug resistance and rapid clinical course to AIDS.
Previous research suggests that the likelihood of progression to AIDS in 6 months is seven per 10,000, and in 12 months is 45 per 10,000 individuals. The cause of the rapid disease progression may be due to a particularly aggressive form of HIV.
However, studies looking into this are ongoing and currently incomplete. The authors note that the public health ramifications of this case are great, since the patient reported having unprotected sex with multiple partners.
Preventive, Not Punitive, Measures Needed
“Only additional investigations will reveal whether this case is isolated or not," Dr. Markowitz states. "Irrespective of the outcome, efforts to prevent HIV-1 transmission need to be intensified, with particular emphasis on the epidemic that is being propelled by the use of methamphetamine. However, in doing so, care should be taken to avoid punitive measures against the populations most vulnerable to HIV-1.”
In an accompanying editorial, The Lancet comments: “This case serves as a reminder that HIV remains a frighteningly versatile foe -- one that can mutate to escape immune attack or to acquire drug resistance with surprising speed.
"One lesson to be drawn from this case, therefore, is that despite all the advances that have been made in understanding this virus, and all the progress that has been made in developing new drugs, prevention remains the most effective strategy to combat HIV -- especially prevention efforts that target high-risk groups, such as men who have sex with men, intravenous drug users, and sex workers and their clients.” |